Leadership
GBM AGILE
About GBM AGILE
GBM AGILE Trial Sites
FAQs
Strategic Partners
REMAP-COVID
About REMAP-COVID
REMAP-COVID US Trial Sites
Ovarian CanceRx
News
Join Us
Contact
DONATE
< Back to News
GBM AGILE Opens to Paxalisib in Europe
MAY 31, 2022 | KAZIA THERAPEUTICS
https://www.kaziatherapeutics.com/site/PDF/0ad7a061-1457-45b0-841e-e84b9feeaf76/GBMAgileopenstopaxalisibinEurope
Home
Leadership
About REMAP-COVID
REMAP-COVID US Trial Sites
Ovarian CanceRx
GBM AGILE
About GBM AGILE
GBM AGILE Trial Sites
FAQs
Strategic Partners
News
Join Us
Contact
DONATE